A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

Completed · Phase 2

Conditions studied: Osteoarthritis, Knee

In brief

The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.

Key facts

Study ID

NCT00265304

Run by

IDEA AG

People needed

550

Starts

2005-07-01

Last updated by the study team

2009-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who completed Study 17-007 or discontinued from Study 17-007 due to lack of efficacy
• Patients who did not complete or discontinue from Study 17-007 must have osteoarthritis of both knees for a minimum of six months
• Have moderate pain in the most involved knee when not taking non-steroidal anti-inflammatory drugs (NSAIDs)
• Must have used an oral NSAID on at least three days per week for the last three months, or 25 of the 30 days before screening
• Demonstrate x-ray evidence of osteoarthritis in the most involved knee during the last six months

You may not qualify if…

• Any patient currently receiving physical therapy to either knee or having a history of allergy, hypersensitivity or contraindication to ketoprofen, naproxen, or acetaminophen, an NSAID idiosyncrasy, or any other medical condition that would compromise the ability of the subject to complete the required assessments and visits
• For patients who did not participate in Study 17-007: having Grade 1 or Grade 4 severity of the most involved knee based on x-ray criteria
• Received intra-articular injections or arthroscopy of the most involved knee during three months before screening visit
• Have a large bulging effusion, or have inflammation of the most involved knee that could be related to gout, pseudogout-induced synovitis, or infection
• Have a history of partial or total knee replacement in either knee, or have a history of gout, pseudo-gout induced synovitis, or infection of the more severe knee

Where it is running

• Study site — Montgomery, Alabama, United States
• Study site — Montgomery, Alabama, United States
• Study site — Northport, Alabama, United States
• Study site — Mesa, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tempe, Arizona, United States
• Study site — Anaheim, California, United States
• Study site — Encinitas, California, United States
• Study site — Fair Oaks, California, United States
• Study site — Garden Grove, California, United States
• Study site — Irvine, California, United States
• Study site — Paramount, California, United States
• Study site — Rancho Mirage, California, United States
• Study site — San Diego, California, United States
• Study site — Spring Valley, California, United States
• Study site — Vista, California, United States
• Study site — Northglenn, Colorado, United States
• Study site — Danbury, Connecticut, United States
• Study site — Clearwater, Florida, United States
• Study site — Coral Gables, Florida, United States
• Radiant Research-daytona — Daytona Beach, Florida, United States
• Study site — DeLand, Florida, United States
• Study site — Fort Myers, Florida, United States
• Study site — Gainesville, Florida, United States
• Capstone Clinical Trials Inc — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.